Cannabis use safe for heart, study suggests

30/10/2023
A doctor holding a cannabis leaf

Unveiling the relationship between cannabis and cardiovascular health

In a significant stride towards demystifying the health implications of cannabis, recent data published in the journal Circulation, Cardiovascular Quality and Outcomes reveals that middle-aged adults who consume cannabis do not face an increased risk of atherosclerosis—commonly known as the hardening of the arteries—compared to those who have never used the substance.

Study parameters and demographics

Researchers at the University of Pittsburgh Medical Center spearheaded an investigation to discern the potential link between marijuana use and adverse atherosclerotic cardiovascular disease (ASCVD).

The study encompassed a nationally representative cohort of nearly 14,000 adults aged between 18 and 59, providing a comprehensive overview of the issue at hand.

Key findings on cannabis consumption and heart health

Despite cannabis consumers reporting higher instances of tobacco use—a well-known contributor to atherosclerosis—the study found no increased risk of the disease in cannabis users when compared to non-users. This aligns with the outcomes of other longitudinal trials that have similarly found no significant association between cannabis use and cardiovascular disease.

Additional health observations in cannabis users

Interestingly, the study also noted that individuals with a history of cannabis consumption were less likely to experience diabetes or obesity—two conditions often linked to heart disease. This observation is in harmony with prior research that has suggested potential metabolic benefits associated with cannabis use.

Implications for public health and policy

The researchers concluded with a clear message: the study found no connection between self-reported marijuana use and an increased burden of traditional ASCVD risk factors, estimated long-term ASCVD risk, or cardiometabolic profiles. This finding could have significant implications for public health policies and the perception of cannabis use in medical and recreational settings.

Comparative analysis with tobacco use

While cannabis users in the study were more inclined to smoke tobacco, the absence of a higher risk of heart disease among them suggests that the effects of cannabis on cardiovascular health may differ substantially from those of tobacco, a substance with a well-documented negative impact on heart health.

Revisiting the narrative on cannabis and health

The narrative surrounding cannabis and its health implications has often been fraught with controversy and uncertainty. This study serves to challenge some of the long-held beliefs about the dangers of cannabis use, particularly concerning heart health, and calls for a re-evaluation of the substance's overall risk profile.

Future research directions

While the findings are promising, the cross-sectional nature of the study underscores the need for further longitudinal research to fully understand the long-term cardiovascular effects of cannabis use. Such research is crucial to inform evidence-based policy and healthcare decisions.

Broader context of cannabis research

The study is part of a growing body of research that seeks to understand the comprehensive effects of cannabis on various aspects of health. It contributes to a nuanced discussion about the role of cannabis in society and its potential therapeutic benefits.

This pivotal research from the University of Pittsburgh Medical Center offers a new perspective on the health implications of cannabis use, particularly in relation to cardiovascular disease. It underscores the importance of evidence-based discourse on the topic and the need for continued research in this field.

    Back to blog

    Leave a comment

    Please note, comments need to be approved before they are published.

    Robin Roy Krigslund-Hansen

    Robin Roy Krigslund-Hansen

    About the author:

    Robin Roy Krigslund-Hansen is known for his extensive knowledge and expertise in the fields of CBD and hemp production. With a career spanning over a decade in the cannabis industry, he has dedicated his life to understanding the intricacies of these plants and their potential benefits to human health and the environment. Over the years, Robin has worked tirelessly to promote the full legalization of hemp in Europe. His fascination with the plant's versatility and potential for sustainable production led him to pursue a career in the field.

    More about Robin Roy Krigslund-Hansen

    Related products

    1 of 3